Literature DB >> 12879265

Interleukin-18 is regulated by G protein pathways and protein kinase signals in human fibroblasts.

Marc K Schuler1, Wilhelm K Aicher.   

Abstract

Interleukin-18 (IL-18) is a member of the IL-1 cytokine family and has proinflammatory activity. It has been detected in osteoarthritic (OA) and at higher levels in rheumatoid arthritic (RA) synovial tissue. Therefore we investigated major signal transduction pathways for their contribution to IL-18 expression. Here we report that cyclic adenosine monophosphate reduced and ionomycin increased IL-18 mRNA in RA synovial fibroblasts (SF) but not in OA SF. Moreover, activation of G-proteins by Mas-7 augmented IL-18 reverse transcriptase polymerase chain reaction signals in OA SF but not in RA SF. Specific protein kinase C activator phorbol myristate acetate reduced transcription and secretion of IL-18 in RA SF and OA SF. Staurosporine changed spontaneous IL-18 mRNA levels and increased the secretion of IL-18 protein. We conclude that G-protein activation and protein kinase C activation might partially be responsible for elevated IL-18 levels during RA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12879265     DOI: 10.1007/s00296-003-0321-4

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  27 in total

1.  Metabolic activation stimulates acid production in synovial fibroblasts.

Authors:  W J Parak; S Dannöhl; M George; M K Schuler; J Schaumburger; H E Gaub; O Müller; W K Aicher
Journal:  J Rheumatol       Date:  2000-10       Impact factor: 4.666

2.  Protein kinase signals activate interleukin 16 encoding transcripts in rheumatoid arthritis versus osteoarthritis synovial fibroblasts.

Authors:  M K Schuler; S Sell; W K Aicher
Journal:  Ann Rheum Dis       Date:  2003-02       Impact factor: 19.103

3.  Interleukin-18 stimulates HIV-1 replication in a T-cell line.

Authors:  S A Klein; C Klebba; D Kauschat; M Pape; L Ozmen; D Hoelzer; O G Ottmann; U Kalina
Journal:  Eur Cytokine Netw       Date:  2000-03       Impact factor: 2.737

4.  Expression of the collagenolytic and Ras-induced cysteine proteinase cathepsin L and proliferation-associated oncogenes in synovial cells of MRL/I mice and patients with rheumatoid arthritis.

Authors:  A Trabandt; W K Aicher; R E Gay; V P Sukhatme; M Nilson-Hamilton; R T Hamilton; J R McGhee; H G Fassbender; S Gay
Journal:  Matrix       Date:  1990-12

5.  Potent antitumor effects mediated by local expression of the mature form of the interferon-gamma inducing factor, interleukin-18 (IL-18).

Authors:  T Osaki; W Hashimoto; A Gambotto; H Okamura; P D Robbins; M Kurimoto; M T Lotze; H Tahara
Journal:  Gene Ther       Date:  1999-05       Impact factor: 5.250

6.  Virus infection activates IL-1 beta and IL-18 production in human macrophages by a caspase-1-dependent pathway.

Authors:  J Pirhonen; T Sareneva; M Kurimoto; I Julkunen; S Matikainen
Journal:  J Immunol       Date:  1999-06-15       Impact factor: 5.422

7.  Interleukin-18 regulation of interferon gamma production and cell proliferation as shown in interleukin-1beta-converting enzyme (caspase-1)-deficient mice.

Authors:  G Fantuzzi; A J Puren; M W Harding; D J Livingston; C A Dinarello
Journal:  Blood       Date:  1998-03-15       Impact factor: 22.113

8.  Interleukin-16, produced by synovial fibroblasts, mediates chemoattraction for CD4+ T lymphocytes in rheumatoid arthritis.

Authors:  J K Franz; S A Kolb; K M Hummel; F Lahrtz; M Neidhart; W K Aicher; T Pap; R E Gay; A Fontana; S Gay
Journal:  Eur J Immunol       Date:  1998-09       Impact factor: 5.532

9.  Selective induction of cell cycle regulatory genes cdk1 (p34cdc2), cyclins A/B, and the tumor suppressor gene Rb in transformed cells by okadaic acid.

Authors:  J You; R C Bird
Journal:  J Cell Physiol       Date:  1995-08       Impact factor: 6.384

10.  Direct activation of human CD8+ cytotoxic T lymphocytes by interleukin-18.

Authors:  M Kohyama; K Saijyo; M Hayasida; T Yasugi; M Kurimoto; T Ohno
Journal:  Jpn J Cancer Res       Date:  1998-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.